|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Á¦ ¸ñ |
MeCDUpsarkC |
|
ÀÌ ¸§ |
Wilmer |
³¯ Â¥ |
2018/06/29 |
Á¶ ȸ |
1 |
|
What line of work are you in? generics pharmacy franchise cost This gives the medicine an advantage over Actelion's olderproduct and current main seller, Tracleer, which had sales of1.5 billion Swiss francs ($1.66 billion) in 2012 but losespatent protection from 2015.
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|